CN116870120B - 一种治疗乳腺小叶增生的中药组合物及其制备方法和应用 - Google Patents
一种治疗乳腺小叶增生的中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN116870120B CN116870120B CN202310969309.0A CN202310969309A CN116870120B CN 116870120 B CN116870120 B CN 116870120B CN 202310969309 A CN202310969309 A CN 202310969309A CN 116870120 B CN116870120 B CN 116870120B
- Authority
- CN
- China
- Prior art keywords
- parts
- mammary glands
- chinese medicine
- traditional chinese
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010020718 hyperplasia Diseases 0.000 title claims abstract description 50
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 210000005075 mammary gland Anatomy 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 210000000582 semen Anatomy 0.000 claims abstract description 32
- 206010062717 Increased upper airway secretion Diseases 0.000 claims abstract description 18
- 208000026435 phlegm Diseases 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 16
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 16
- 241000893536 Epimedium Species 0.000 claims abstract description 16
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 16
- 235000018905 epimedium Nutrition 0.000 claims abstract description 16
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 15
- 241001474374 Blennius Species 0.000 claims abstract description 15
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 14
- 235000011437 Amygdalus communis Nutrition 0.000 claims abstract description 14
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 14
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 14
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 14
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 14
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 14
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 14
- 235000020224 almond Nutrition 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 240000000249 Morus alba Species 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 13
- 244000061508 Eriobotrya japonica Species 0.000 claims abstract 5
- 238000002156 mixing Methods 0.000 claims description 43
- 239000000843 powder Substances 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 239000011812 mixed powder Substances 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 25
- 238000010298 pulverizing process Methods 0.000 claims description 21
- 238000002791 soaking Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000007873 sieving Methods 0.000 claims description 14
- 241000209020 Cornus Species 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 7
- 241000195474 Sargassum Species 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 7
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 7
- 229920006316 polyvinylpyrrolidine Polymers 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 10
- 240000006766 Cornus mas Species 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 11
- 241001092070 Eriobotrya Species 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 238000011282 treatment Methods 0.000 description 8
- 206010006272 Breast mass Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 239000013641 positive control Substances 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000002445 nipple Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000030270 breast disease Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000002175 menstrual effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010006298 Breast pain Diseases 0.000 description 3
- 240000009138 Curcuma zedoaria Species 0.000 description 3
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 3
- 208000006662 Mastodynia Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 235000019509 white turmeric Nutrition 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010006312 Breast swelling Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 206010006256 Breast hyperplasia Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164480 Curcuma aromatica Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000000571 Fibrocystic breast disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011803 breast fibrocystic disease Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229950002007 estradiol benzoate Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 201000004535 ovarian dysfunction Diseases 0.000 description 1
- 231100000543 ovarian dysfunction Toxicity 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007119 pathological manifestation Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000011273 social behavior Effects 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
本发明公开了一种治疗乳腺小叶增生的中药组合物,由以下重量份的原料药提取制备而成:川芎15‑25份、红花10‑20份、生蒲黄10‑18份、莪术8‑12份、淫羊藿15‑25份、菟丝子20‑28份、山茱萸20‑24份、枸杞子15‑25份、玄参12‑18份、女贞子20‑30份、桑白皮15‑25份、杏仁12‑18份、枇杷叶15‑25份、苏梗10‑18份、海藻12‑18份、昆布20‑30份、瓦楞子18‑22份、陈皮15‑25份、枳壳10‑20份,并公开了其制备方法,本发明治疗痰瘀凝滞型乳腺小叶增生效果显著。
Description
技术领域
本发明属于医药领域,具体涉及一种治疗乳腺小叶增生的中药组合物及其制备方法和应用。
背景技术
乳腺小叶增生是乳腺增生性疾病中最为常见的一种非肿瘤、非炎症性的增生性病变,均占乳房疾病中的70%左右,可发生于青春期以后的任何年龄的妇女。本病是因为卵巢功能紊乱致使雌激素水平过高、与黄体素的比例失调所致的一种常见的乳腺良性病变,以乳腺腺泡及导管末段的上皮细胞过度增生为主要病理特征。本病命名繁多混乱。如乳腺小叶增生症、囊性乳腺病、乳腺囊性增生病、纤维囊性病等,WHO乳腺病变分类命名为乳腺结构不良。
目前针对肝纤维化的治疗局限于控制病因,缺乏理想的治疗药物。中医认为肝肾两经与乳房关系最密切,其次是冲任两脉。肝郁气滞、情志内伤在乳腺小叶增生的病因中有重要影响。平素情志抑郁,气滞不舒,气血周流失度,蕴结于乳房胃络,乳络经脉阻塞不通,不通则痛而引起乳房疼痛;肝气横逆犯胃,脾失健运,痰浊内生,气滞血瘀挟痰结聚为核,循经留聚乳中,故乳中结块。肝肾不足,冲任失调也是重要的乳腺小叶增生的原因。
发明内容
针对现有技术的不足,本发明的目的是提供一种治疗乳腺小叶增生的中药组合物及其制备方法和应用。
本发明的另一个目的是提供一种痰瘀凝滞型乳腺小叶增生的中药组合物及其制备方法和应用。
为了实现上述目的,本发明的技术方案是:
一种治疗乳腺小叶增生的中药组合物,由以下重量份的原料药提取制备而成:川芎15-25份、红花10-20份、生蒲黄10-18份、莪术8-12份、淫羊藿15-25份、菟丝子20-28份、山茱萸20-24份、枸杞子15-25份、玄参12-18份、女贞子20-30份、桑白皮15-25份、杏仁12-18份、枇杷叶15-25份、苏梗10-18份、海藻12-18份、昆布20-30份、瓦楞子18-22份、陈皮15-25份、枳壳10-20份。
所述的治疗乳腺小叶增生的中药组合物,由以下重量份的原料药提取制备而成:川芎20份、红花15份、生蒲黄14份、莪术10份、淫羊藿20份、菟丝子24份、山茱萸22份、枸杞子20份、玄参15份、女贞子25份、桑白皮20份、杏仁15份、枇杷叶20份、苏梗14份、海藻15份、昆布25份、瓦楞子20份、陈皮20份、枳壳15份。
所述的治疗乳腺小叶增生的中药组合物,由以下重量份的原料药提取制备而成:川芎15份、红花20份、生蒲黄10份、莪术12份、淫羊藿15份、菟丝子28份、山茱萸20份、枸杞子25份、玄参12份、女贞子30份、桑白皮15份、杏仁18份、枇杷叶15份、苏梗18份、海藻12份、昆布30份、瓦楞子18份、陈皮25份、枳壳10份。
所述的治疗乳腺小叶增生的中药组合物,由以下重量份的原料药提取制备而成:川芎25份、红花10份、生蒲黄18份、莪术8份、淫羊藿25份、菟丝子20份、山茱萸24份、枸杞子15份、玄参18份、女贞子20份、桑白皮25份、杏仁12份、枇杷叶25份、苏梗10份、海藻18份、昆布20份、瓦楞子22份、陈皮15份、枳壳20份。
所述的治疗乳腺小叶增生的中药组合物,将中药组合物制成口服制剂。
所述的治疗乳腺小叶增生的中药组合物,口服制剂为水煎剂、口服液、颗粒剂、片剂、胶囊剂、丸剂中的一种。
所述的治疗乳腺小叶增生的中药组合物,水煎剂的制备方法为:将原料药混合,加混合原料药10~20倍重量的水,浸泡1.5~3小时后,煎煮60~120分钟,过滤;滤渣再加滤渣10~20倍重量的水,煎煮30~60分钟,过滤;合并两次滤液,制成水煎剂。
所述的治疗乳腺小叶增生的中药组合物,口服液的制备方法为:将原料药混合,加混合原料药10~20倍重量的水,浸泡1.5~3小时后,煎煮60~120分钟,过滤;滤渣再加滤渣10~20倍重量的水,煎煮30~60分钟,过滤;合并两次滤液,制成口服液。
所述的治疗乳腺小叶增生的中药组合物,颗粒剂的制备方法为:
1)取川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁药材混合并粉碎成粗粉,加粗粉10~20倍重量的50~80%(v/v)乙醇,浸泡1~3小时,然后回流提取2~3次,每次1~2小时,合并提取液,回收乙醇,浓缩提取液,真空干燥,得提取物,将提取物粉碎成细粉,过80目筛;
2)取枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳,混合,按照料液比1:10加入水,浸泡1~2小时,回流提取,提取液浓缩,干燥得提取物,将提取物粉碎成细粉,过80目筛;
3)将步骤1)和步骤2)所得过筛提取物粉末混合,加入混合粉1.0~1.5倍重量的微晶纤维素,0.5~0.9倍重量的乳糖、1.5~2.0倍重量的质量分数5%聚乙烯吡咯烷酮K30水溶液,混合均匀,制粒,干燥,整粒,装袋,即得。
所述的治疗乳腺小叶增生的中药组合物,片剂的制备方法为:
1)取川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁药材混合并粉碎成粗粉,加粗粉10~20倍重量的50~80%(v/v)乙醇,浸泡1~3小时,然后回流提取2~3次,每次1~2小时,合并提取液,回收乙醇,浓缩提取液,真空干燥,得提取物,将提取物粉碎成细粉,过80目筛;
2)取枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳,混合,按照料液比1:10加入水,浸泡1~2小时,回流提取,提取液浓缩,干燥得提取物,将提取物粉碎成细粉,过80目筛;
3)将步骤1)和步骤2)所得过筛提取物粉末混合,加入混合粉1.0~1.5倍重量的微晶纤维素,0.5~0.9倍重量的乳糖、1.5~2.0倍重量的质量分数5%聚乙烯吡咯烷酮K30水溶液,0.03~0.07倍重量的滑石粉,混合均匀,制粒,压片,即得。
所述的治疗乳腺小叶增生的中药组合物,胶囊剂的制备方法为:
1)取川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁药材混合并粉碎成粗粉,加粗粉10~20倍重量的50~80%(v/v)乙醇,浸泡1~3小时,然后回流提取2~3次,每次1~2小时,合并提取液,回收乙醇,浓缩提取液,真空干燥,得提取物,将提取物粉碎成细粉,过80目筛;
2)取枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳,混合,按照料液比1:10加入水,浸泡1~2小时,回流提取,提取液浓缩,干燥得提取物,将提取物粉碎成细粉,过80目筛;
3)将步骤1)和步骤2)所得过筛提取物粉末混合,加入混合粉1.0~1.5倍重量的微晶纤维素,0.5~0.9倍重量的乳糖、1.5~2.0倍重量的质量分数5%聚乙烯吡咯烷酮K30水溶液,0.03~0.07倍重量的滑石粉,混合均匀,灌胶囊,即得胶囊剂。
所述的治疗乳腺小叶增生的中药组合物在制备治疗乳腺小叶增生药物中的应用,乳腺小叶增生的证型为痰瘀凝滞型。
本发明所述的重量份可以是μg、mg、g或kg等医药领域公知的重量单位。
痰瘀凝滞型乳腺增生,此类患者乳房结块,经久难消,胀痛或刺痛,触之肿块质地硬,患者平素痰多,粘稠,烦躁易怒,失眠多梦,情绪波动时症状加重,月经量少,色暗,有血块,经期腹痛。舌质黯红有瘀血斑点,脉来细涩。从病理上讲就是痰湿和血瘀,中医上讲肝疏泄失职,脾湿运化,怒则伤肝,肝气郁结形成气滞血瘀,脾湿运化,水湿主流化为痰,所以叫痰湿。痰液互相交接发为乳癖,形成乳腺疾病。本发明通过如下方法来治疗痰瘀凝滞型乳腺小叶增生,一是活血化瘀;二是补肾固实,调理冲任;三是抑制肝阳上亢和肝气郁结;四是疏肝化痰;五是结者散之,消除乳房结块;六是行气。
本发明采用川芎、红花、生蒲黄、莪术活血化瘀,淫羊藿、菟丝子补肾固实,调理冲任,川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子共为君药;山茱萸、枸杞子、玄参、女贞子能滋水涵木,抑制肝阳上亢和肝气郁结,桑白皮、杏仁、枇杷叶、苏梗佐金平木,能疏肝化痰,山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁、枇杷叶、苏梗为臣药;海藻、昆布、瓦楞子结者散之,消除乳房结块,为佐药;陈皮、枳壳行气,为使药,全方(川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁、枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳)治疗痰瘀凝滞型乳腺小叶增生效果显著。
具体实施方式
下面结合具体实施方式,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明记载的内容之后,本领域技术人员可以对本发明作各种改动或修改,但这些等价形式同样落于本申请所附权利要求书所限定的范围。
实施例1:
取川芎20g、红花15g、生蒲黄14g、莪术10g、淫羊藿20g、菟丝子24g、山茱萸22g、枸杞子20g、玄参15g、女贞子25g、桑白皮20g、杏仁15g、枇杷叶20g、苏梗14g、海藻15g、昆布25g、瓦楞子20g、陈皮20g、枳壳15g,制备方法为:
1)取川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁药材混合并粉碎成粗粉,加粗粉20倍重量的50%(v/v)乙醇,浸泡3小时,然后回流提取2次,每次2小时,合并提取液,回收乙醇,浓缩提取液,真空干燥,得提取物,将提取物粉碎成细粉,过80目筛;
2)取枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳,混合,按照料液比1:10加入水,浸泡1小时,回流提取,提取液浓缩,干燥得提取物,将提取物粉碎成细粉,过80目筛;
3)将步骤1)和步骤2)所得过筛提取物粉末混合,加入混合粉1.5倍重量的微晶纤维素,0.5倍重量的乳糖、2.0倍重量的质量分数5%聚乙烯吡咯烷酮K30水溶液,混合均匀,制粒,干燥,整粒,装袋,即得。
实施例2:
取川芎15g、红花20g、生蒲黄10g、莪术12g、淫羊藿15g、菟丝子28g、山茱萸20g、枸杞子25g、玄参12g、女贞子30g、桑白皮15g、杏仁18g、枇杷叶15g、苏梗18g、海藻12g、昆布30g、瓦楞子18g、陈皮25g、枳壳10g,制备方法为:
1)取川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁药材混合并粉碎成粗粉,加粗粉10倍重量的80%(v/v)乙醇,浸泡1小时,然后回流提取3次,每次1小时,合并提取液,回收乙醇,浓缩提取液,真空干燥,得提取物,将提取物粉碎成细粉,过80目筛;
2)取枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳,混合,按照料液比1:10加入水,浸泡2小时,回流提取,提取液浓缩,干燥得提取物,将提取物粉碎成细粉,过80目筛;
3)将步骤1)和步骤2)所得过筛提取物粉末混合,加入混合粉1.0倍重量的微晶纤维素,0.9倍重量的乳糖、1.5倍重量的质量分数5%聚乙烯吡咯烷酮K30水溶液,0.03~0.07倍重量的滑石粉,混合均匀,制粒,压片,即得。
实施例3:
取川芎25g、红花10g、生蒲黄18g、莪术8g、淫羊藿25g、菟丝子20g、山茱萸24g、枸杞子15g、玄参18g、女贞子20g、桑白皮25g、杏仁12g、枇杷叶25g、苏梗10g、海藻18g、昆布20g、瓦楞子22g、陈皮15g、枳壳20g,制备方法为:将原料药混合,加混合原料药15倍重量的水,浸泡2小时后,煎煮90分钟,过滤;滤渣再加滤渣15倍重量的水,煎煮45分钟,过滤;合并两次滤液,制成水煎剂。
实施例4:考察实施例1中药组合物对SD大鼠乳腺增生的治疗效果,具体如下:
1.实验动物:SD大鼠40只,雌性未孕,体重180-220g,饲喂颗粒饲料,观察性饲养1周后进入实验期。其中10只每两天注射一次生理盐水(0.02mL/kg),共注射15次,作为空白组;其余30只为实施例1组、模型组和阳性对照组,三组每两天分别在两只大腿肌肉注射苯甲酸雌二醇(0.3mg/kg;天津金耀药业有限公司)和黄体酮(4mg/kg;天津金耀药业有限公司),共注射15次,形成乳腺增生病模型。
2.实验药品:分别取实施例1制备得到的组合物,加水溶解为20mg/mL的溶液,备用。
乳癖消片(辽宁好护士药业(集团)有限公司,国药准字Z20121823)碾碎,加水溶解为20mg/mL的溶液,作为阳性对照组大鼠受试药物备用。
3.实验过程:将造模后的大鼠随机分为3组(实施例1组、模型组和阳性对照组),实施例1组分别给予实施例1的颗粒剂,每天灌胃一次,每次10mL/kg;阳性对照组给予乳癖消溶液,每天灌胃一次,每次10mL/kg;空白组和模型组给予生理盐水10mL/kg,每天一次。连续灌胃一个月后,末次给药后,禁食24h,然后用游标卡尺测量大鼠乳房直径以及乳头高度,结果见表1。
表1各组大鼠乳房直径和乳头高度
组别 | 乳房直径(mm) | 乳头高度(mm) |
空白组 | 1.14±0.23 | 1.43±0.32 |
模型组 | 1.96±0.32** | 2.25±0.41** |
阳性药组 | 1.33±0.16△△ | 1.78±0.25△△ |
实施例1组 | 1.16±0.18△△ | 1.46±0.42△△ |
注:与空白组相比,*P<0.05,**P<0.01;与模型组比较,△P<0.05,△△P<0.01。
表1数据可以看出,模型组与空白组存在极显著性差异,说明造模成功。阳性对照组与模型组相比,乳房直径和乳头高度均有显著性差异,证明乳癖消片可以有效改善乳腺增生带来的乳房肿胀问题。实施例1组相比于模型组,乳房直径和乳头高度均有显著性差异,证明本发明实施例1也可以抑制乳腺增生,有效改善乳腺增生带来的乳房肿胀问题,并且效果优于阳性对照组,即乳癖消片。
另外,在进行上述实验过程中,实验组各组小鼠均无死亡,给药后观察小鼠外观、毛色、光泽正常,社会行为、反应均正常,摄食、排泄正常。说明本发明组合物安全性可靠。
实施例5:临床试验
1.临床资料自2020年7月至2022年3月间,南京市中医院门诊符合病例选择标准的乳腺增生患者200例,年龄在24~54岁,平均32.43岁,病程5个月~6年,平均1.9±1.2年,随机分为本发明组和对照组。
2.诊断标准参照《外科学》有关乳腺增生症的诊断标准。(陈考平,汪建平.外科学[M].8版.北京.人民卫生出版社,2013.254-255)。中医诊断标准,符合痰瘀凝滞型乳腺增生,患者乳房结块,经久难消,胀痛或刺痛,触之肿块质地硬,患者平素痰多,粘稠,烦躁易怒,失眠多梦,情绪波动时症状加重,月经量少,色暗,有血块,经期腹痛。舌质黯红有瘀血斑点,脉来细涩。
3.纳入标准:(1)符合《外科学》乳腺增生症的诊断标准(2)年龄在18至55岁之间。
4.排除标准:(1)妊娠期及哺乳期(2)乳腺炎、乳腺恶性肿瘤(3)服用所有激素类药物者(4)有严重的心肝肾疾患者(5)精神病患者。
5.治疗方法:本发明组应用本发明实施例1制备的颗粒剂,分早晚两次温服(每日用量:川芎20g、红花15g、生蒲黄14g、莪术10g、淫羊藿20g、菟丝子24g、山茱萸22g、枸杞子20g、玄参15g、女贞子25g、桑白皮20g、杏仁15g、枇杷叶20g、苏梗14g、海藻15g、昆布25g、瓦楞子20g、陈皮20g、枳壳15g)。经期不停药,连用四周为一疗程。对照组服用乳癖消片(辽宁好护士药业(集团)有限公司,国药准字Z20121823),口服,一次3片,一日三次。
6.观察指标中医证候积分:治疗4周后,记录2组中医证候积分,包括乳房疼痛积分,乳房肿块(大小、质地)积分。(1)乳房疼痛积分采用公认的视觉模拟评分法(VAS)疼痛评分标准。0分为无痛;1~3分为轻度疼痛,患者能忍受;4-6分为疼痛并影响睡眠,患者尚能忍受;7~10分为有渐强的疼痛感,患者疼痛难忍,影响食欲及睡眠。由患者本人将疼痛分级圈于相应的数字上。(2)乳房肿块大小评分。无肿块计0分;肿块长径≤1cm计1分;肿块长径>1cm,且≤2cm计2分;肿块长径>2cm计3分。(3)乳房肿块质地评分。无肿块计0分;肿块质尚软计1分;肿块质韧计2分;肿块质韧硬计3分。
7.疗效判定:参照《中药新药临床研究指导原则》制定。(1)临床痊愈:治疗后乳房疼痛消失,乳房肿块消失,证候积分值为0;(2)显效:治疗后中医证候积分值减少≥70%,或肿块长径缩小一半以上;(3)有效:治疗后中医证候积分值减少≥30%且<70%,或肿块长径缩小三分之一以上;(4)无效:不符合以上标准者。总有效率=(临床痊愈+显效+进步)/总例数×100%。
8.治疗效果:本发明组痊愈42例,显效28,有效21例,无效9例,总有效率91%,对照组痊愈12例,显效25,有效18例,无效45例,总有效率55%,说明本发明治疗痰瘀凝滞型乳腺增生效果显著,而且本发明效果好于对照组。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (10)
1.一种治疗乳腺小叶增生的中药组合物,其特征在于,由以下重量份的原料药提取制备而成:川芎15-25份、红花10-20份、生蒲黄10-18份、莪术8-12份、淫羊藿15-25份、菟丝子20-28份、山茱萸20-24份、枸杞子15-25份、玄参12-18份、女贞子20-30份、桑白皮15-25份、杏仁12-18份、枇杷叶15-25份、苏梗10-18份、海藻12-18份、昆布20-30份、瓦楞子18-22份、陈皮15-25份、枳壳10-20份。
2.根据权利要求1所述的治疗乳腺小叶增生的中药组合物,其特征在于,由以下重量份的原料药提取制备而成:川芎20份、红花15份、生蒲黄14份、莪术10份、淫羊藿20份、菟丝子24份、山茱萸22份、枸杞子20份、玄参15份、女贞子25份、桑白皮20份、杏仁15份、枇杷叶20份、苏梗14份、海藻15份、昆布25份、瓦楞子20份、陈皮20份、枳壳15份。
3.根据权利要求1所述的治疗乳腺小叶增生的中药组合物,其特征在于,由以下重量份的原料药提取制备而成:川芎15份、红花20份、生蒲黄10份、莪术12份、淫羊藿15份、菟丝子28份、山茱萸20份、枸杞子25份、玄参12份、女贞子30份、桑白皮15份、杏仁18份、枇杷叶15份、苏梗18份、海藻12份、昆布30份、瓦楞子18份、陈皮25份、枳壳10份。
4.根据权利要求1所述的治疗乳腺小叶增生的中药组合物,其特征在于,由以下重量份的原料药提取制备而成:川芎25份、红花10份、生蒲黄18份、莪术8份、淫羊藿25份、菟丝子20份、山茱萸24份、枸杞子15份、玄参18份、女贞子20份、桑白皮25份、杏仁12份、枇杷叶25份、苏梗10份、海藻18份、昆布20份、瓦楞子22份、陈皮15份、枳壳20份。
5.根据权利要求1所述的治疗乳腺小叶增生的中药组合物,其特征在于,将中药组合物制成口服制剂。
6.根据权利要求5所述的治疗乳腺小叶增生的中药组合物,其特征在于,口服制剂为水煎剂、口服液、颗粒剂、片剂、胶囊剂、丸剂中的一种。
7.根据权利要求6所述的治疗乳腺小叶增生的中药组合物,其特征在于,水煎剂的制备方法为:将原料药混合,加混合原料药10~20倍重量的水,浸泡1.5~3小时后,煎煮60~120分钟,过滤;滤渣再加滤渣10~20倍重量的水,煎煮30~60分钟,过滤;合并两次滤液,制成水煎剂。
8.根据权利要求6所述的治疗乳腺小叶增生的中药组合物,其特征在于,颗粒剂的制备方法为:
1)取川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁药材混合并粉碎成粗粉,加粗粉10~20倍重量的50~80%(v/v)乙醇,浸泡1~3小时,然后回流提取2~3次,每次1~2小时,合并提取液,回收乙醇,浓缩提取液,真空干燥,得提取物,将提取物粉碎成细粉,过80目筛;
2)取枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳,混合,按照料液比1:10加入水,浸泡1~2小时,回流提取,提取液浓缩,干燥得提取物,将提取物粉碎成细粉,过80目筛;
3)将步骤1)和步骤2)所得过筛提取物粉末混合,加入混合粉1.0~1.5倍重量的微晶纤维素,0.5~0.9倍重量的乳糖、1.5~2.0倍重量的质量分数5%聚乙烯吡咯烷酮K30水溶液,混合均匀,制粒,干燥,整粒,装袋,即得。
9.根据权利要求6所述的治疗乳腺小叶增生的中药组合物,其特征在于,片剂的制备方法为:
1)取川芎、红花、生蒲黄、莪术、淫羊藿、菟丝子、山茱萸、枸杞子、玄参、女贞子、桑白皮、杏仁药材混合并粉碎成粗粉,加粗粉10~20倍重量的50~80%(v/v)乙醇,浸泡1~3小时,然后回流提取2~3次,每次1~2小时,合并提取液,回收乙醇,浓缩提取液,真空干燥,得提取物,将提取物粉碎成细粉,过80目筛;
2)取枇杷叶、苏梗、海藻、昆布、瓦楞子、陈皮、枳壳,混合,按照料液比1:10加入水,浸泡1~2小时,回流提取,提取液浓缩,干燥得提取物,将提取物粉碎成细粉,过80目筛;
3)将步骤1)和步骤2)所得过筛提取物粉末混合,加入混合粉1.0~1.5倍重量的微晶纤维素,0.5~0.9倍重量的乳糖、1.5~2.0倍重量的质量分数5%聚乙烯吡咯烷酮K30水溶液,0.03~0.07倍重量的滑石粉,混合均匀,制粒,压片,即得。
10.根据权利要求1-4任一所述的治疗乳腺小叶增生的中药组合物在制备治疗乳腺小叶增生药物中的应用,乳腺小叶增生的证型为痰瘀凝滞型。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310969309.0A CN116870120B (zh) | 2023-08-03 | 2023-08-03 | 一种治疗乳腺小叶增生的中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310969309.0A CN116870120B (zh) | 2023-08-03 | 2023-08-03 | 一种治疗乳腺小叶增生的中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116870120A CN116870120A (zh) | 2023-10-13 |
CN116870120B true CN116870120B (zh) | 2024-04-12 |
Family
ID=88271517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310969309.0A Active CN116870120B (zh) | 2023-08-03 | 2023-08-03 | 一种治疗乳腺小叶增生的中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116870120B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101176782A (zh) * | 2007-10-29 | 2008-05-14 | 佛山德众药业有限公司 | 治疗乳腺类疾病的中药组合物及其制备方法 |
CN104815292A (zh) * | 2015-05-27 | 2015-08-05 | 沈洪彦 | 一种治疗乳腺小叶增生和乳腺肿瘤的中药组合物 |
CN107929668A (zh) * | 2017-12-08 | 2018-04-20 | 湖南康寿制药有限公司 | 一种治疗乳腺小叶增生和乳腺纤维瘤的乳核内消颗粒及其制备方法 |
-
2023
- 2023-08-03 CN CN202310969309.0A patent/CN116870120B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101176782A (zh) * | 2007-10-29 | 2008-05-14 | 佛山德众药业有限公司 | 治疗乳腺类疾病的中药组合物及其制备方法 |
CN104815292A (zh) * | 2015-05-27 | 2015-08-05 | 沈洪彦 | 一种治疗乳腺小叶增生和乳腺肿瘤的中药组合物 |
CN107929668A (zh) * | 2017-12-08 | 2018-04-20 | 湖南康寿制药有限公司 | 一种治疗乳腺小叶增生和乳腺纤维瘤的乳核内消颗粒及其制备方法 |
Non-Patent Citations (1)
Title |
---|
双通汤治疗乳腺增生症32例;高玉敏;;中国中医药现代远程教育;20111208(23);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN116870120A (zh) | 2023-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102210844B (zh) | 一种治疗慢性肝炎的中药组合物及其制备方法 | |
CN104225006A (zh) | 一种益气通便的中药组合物 | |
CN109568477B (zh) | 一种治疗甲状腺结节的药物组合物及其制备方法和用途 | |
CN110393763B (zh) | 一种治疗产后痔疮的中药组合物、制备方法及其应用 | |
CN115252753B (zh) | 治疗失眠的中药组合物及其应用 | |
CN116870120B (zh) | 一种治疗乳腺小叶增生的中药组合物及其制备方法和应用 | |
CN103285284B (zh) | 一种治疗老年性阴道炎的药物组合物 | |
CN112190645B (zh) | 一种用于治疗由薄型子宫内膜及肾阳虚证导致的月经过少的中药组合物及其应用 | |
WO2022227332A1 (zh) | 一种预防和/或治疗类风湿关节炎的组合物及其制备方法与应用 | |
CN103223149A (zh) | 一种治疗肺癌的中草药组合物 | |
CN111358860A (zh) | 一种改善更年期内分泌的中药组合物及其制备方法和应用 | |
CN106581299B (zh) | 一种改善中老年肾气虚证的中药组合物及其应用 | |
CN114949147B (zh) | 一种治疗慢性咽炎的中药组合物,其制备方法和应用 | |
CN113101330B (zh) | 一种调经组合物及其应用 | |
CN102813875B (zh) | 一种治疗红斑狼疮的中药组合物及其应用 | |
CN115944687B (zh) | 一种改善男性特发性少弱精症的中药组方与一种汤剂和一种片剂 | |
CN113057994B (zh) | 一种败酱活性组分、制备方法及其应用 | |
CN111759997B (zh) | 一种治疗乳腺增生病的中药汤剂 | |
CN108704105A (zh) | 一种治疗脑梗死急性期的中药组合物 | |
CN115770279B (zh) | 用于治疗慢性下肢静脉疾病的中药组合物及其汤剂和制剂 | |
CN115154535B (zh) | 一种改善动脉粥样硬化的中药复方及其制备方法 | |
CN115282229B (zh) | 一种治疗气虚血淤型冠心病的中药组合物及其制备方法 | |
CN108653460B (zh) | 一种治疗慢性荨麻疹的中药组合物及其制备方法 | |
CN107510753B (zh) | 一种治疗难治性咯血的中药组合物及其应用 | |
CN105412244A (zh) | 一种治疗妇科宫颈炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |